Oluwamodupe Cecilia  is an award winning Lecturer and researcher. She obtained her PhD in Biochemistry from Ekiti State University Ado Ekiti, with the project titled “The biochemical evaluation of antidiabetic properties of saponin from Tithonia diversifolia leaves and its toxicological implications” project supervised by Prof. Isaac. G. Adanlawo in collaboration with Dr Rakesh Kundu of Cell Signaling laboratory, Zoology Department Vishva Bharati University, Santiniketan, WB India.  She did her postdoctoral fellowship (as a DBT-TWAS postdoctoral fellow) at India Agricultural Research Institute, New Delhi India.

She was a Lab. Technologist/ Research Scientist at Biochemistry Department Adekunle Ajasin University before joining Olusegun Agagu University of Science and Technology as a Lecturer. She was adjudged the best scientist of the year 2021 in Olusegun Agagu University of Science and Technology by AD scientific world scientist ranking.  She is a recipient of highly competitive international awards and grants such as UNESCO/DBT-TWAS and Research Training Fellowship for Developing Country Scientist (RTF-DCS). She has published more than 30 articles in leading international journals. One of her research findings discovered a bioactive constituent that regenerate damaged pancreatic islet of langahan in type1diabetic model mice.

She was a guest lecturer at University of Vienna Austria for students of doctoral program of ion channel and transporters as molecular drug target (DK MolTag) and pharmaceutical department. She is a member of  Endocrine Society Washington DC, USA, Society of Medicinal Plants for Economic Development South Africa (SOMPED) and Nigerian Society for Biochemistry and Molecular biology. She is currently the Acting director, Olusegun Agagu University Leadership academy. Her research interests are Phytomedicine and Metabolic diseases, molecular biology and bioinformatics in a bid to understand the structures, functions and mechanisms of phytochemicals from medicinal plants towards natural product drug development for diabetes, obesity and other cardiometabolic implications.She attended several workshops and conferences both locally and internationally.